These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 25993553)

  • 1. Midbrain dopamine D2/D3 receptor availability and drug craving are associated with mesocorticolimbic gray matter volume in methamphetamine users.
    Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED
    Mol Psychiatry; 2015 Jun; 20(6):658. PubMed ID: 25993553
    [No Abstract]   [Full Text] [Related]  

  • 2. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
    Morales AM; Kohno M; Robertson CL; Dean AC; Mandelkern MA; London ED
    Mol Psychiatry; 2015 Jun; 20(6):764-71. PubMed ID: 25896164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dopamine receptors in the neurotoxicity of methamphetamine.
    Ares-Santos S; Granado N; Moratalla R
    J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine antagonists on methamphetamine-induced dopamine release in high and low alcohol preference rats.
    Nishiguchi M; Kinoshita H; Kasuda S; Takahashi M; Yamamura T; Matsui K; Ouchi H; Minami T; Hishida S; Nishio H
    Toxicol Mech Methods; 2010 Mar; 20(3):127-32. PubMed ID: 20163290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET dopamine D2 receptors and susceptibility to methamphetamine psychosis.
    Iyo M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():652A-653A. PubMed ID: 1354071
    [No Abstract]   [Full Text] [Related]  

  • 7. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
    Robinson SW; Jarvie KR; Caron MG
    Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood trauma-specific reductions in limbic gray matter volume--reply.
    Van Dam NT; Sinha R
    JAMA Psychiatry; 2015 Apr; 72(4):398-9. PubMed ID: 25830677
    [No Abstract]   [Full Text] [Related]  

  • 9. Childhood trauma-specific reductions in limbic gray matter volume: still in the dark.
    Begemann MJ; Schutte MJ; Sommer IE
    JAMA Psychiatry; 2015 Apr; 72(4):398. PubMed ID: 25830676
    [No Abstract]   [Full Text] [Related]  

  • 10. D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures.
    Larson ER; Ariano MA
    Synapse; 1995 Aug; 20(4):325-37. PubMed ID: 7482292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-immunoreactive structures in the midbrain of methamphetamine abusers.
    Quan L; Ishikawa T; Michiue T; Li DR; Zhao D; Oritani S; Zhu BL; Maeda H
    Leg Med (Tokyo); 2005 May; 7(3):144-50. PubMed ID: 15847821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine: toxicity to dopaminergic neurons.
    Seiden LS
    NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain.
    Bustos G; Abarca J; Campusano J; Bustos V; Noriega V; Aliaga E
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):126-44. PubMed ID: 15572168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation.
    Rosin C; Colombo S; Calver AA; Bates TE; Skaper SD
    Glia; 2005 Dec; 52(4):336-43. PubMed ID: 16078234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent anatomical pattern of D1 and D3 binding and dopamine- and cyclic AMP-regulated phosphoprotein of 32 kDa mRNA expression in the Roman rat strains: Implications for drug addiction.
    Guitart-Masip M; Johansson B; Fernández-Teruel A; Cañete T; Tobeña A; Terenius L; Giménez-Llort L
    Neuroscience; 2006 Nov; 142(4):1231-43. PubMed ID: 17008016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic regulation of mesocorticolimbic dopamine neurons.
    White FJ
    Annu Rev Neurosci; 1996; 19():405-36. PubMed ID: 8833449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The double-hit effect of childhood maltreatment on drug relapse.
    Lupien SJ
    JAMA Psychiatry; 2014 Aug; 71(8):871-2. PubMed ID: 24920198
    [No Abstract]   [Full Text] [Related]  

  • 18. Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity.
    Fornai F; Lenzi P; Lazzeri G; Ferrucci M; Fulceri F; Giorgi FS; Falleni A; Ruggieri S; Paparelli A
    Brain Res; 2007 Jan; 1129(1):174-90. PubMed ID: 17157274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra.
    Reyes S; Cottam V; Kirik D; Double KL; Halliday GM
    Mov Disord; 2013 Sep; 28(10):1351-9. PubMed ID: 23674405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.